Sawa Ito

2.4k total citations
71 papers, 1.2k citations indexed

About

Sawa Ito is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Sawa Ito has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 25 papers in Immunology and 24 papers in Oncology. Recurrent topics in Sawa Ito's work include Hematopoietic Stem Cell Transplantation (25 papers), Immune Cell Function and Interaction (19 papers) and CAR-T cell therapy research (16 papers). Sawa Ito is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Immune Cell Function and Interaction (19 papers) and CAR-T cell therapy research (16 papers). Sawa Ito collaborates with scholars based in United States, United Kingdom and Japan. Sawa Ito's co-authors include A. John Barrett, Minoo Battiwalla, A. John Barrett, Pawel Muranski, Nancy F. Hensel, Keyvan Keyvanfar, Xingmin Feng, Sachiko Kajigaya, Neal S. Young and Priyanka A. Pophali and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sawa Ito

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sawa Ito United States 18 466 466 288 249 235 71 1.2k
Mojtaba Akhtari United States 19 444 1.0× 263 0.6× 190 0.7× 290 1.2× 394 1.7× 77 1.2k
Deog‐Yeon Jo South Korea 20 519 1.1× 405 0.9× 283 1.0× 332 1.3× 422 1.8× 105 1.3k
Fumihiko Ishimaru Japan 21 358 0.8× 329 0.7× 125 0.4× 249 1.0× 309 1.3× 93 1.1k
Mireia Camós Spain 22 576 1.2× 329 0.7× 500 1.7× 502 2.0× 547 2.3× 57 1.8k
Pasquale Iacopino Italy 21 774 1.7× 294 0.6× 394 1.4× 255 1.0× 405 1.7× 72 1.3k
Jean Pierre Marolleau France 17 263 0.6× 221 0.5× 191 0.7× 198 0.8× 324 1.4× 53 977
Jérôme Rey France 22 596 1.3× 605 1.3× 527 1.8× 307 1.2× 347 1.5× 76 1.4k
Katsumichi Fujimaki Japan 19 419 0.9× 153 0.3× 254 0.9× 171 0.7× 330 1.4× 85 1.1k
Carlos Panizo Spain 19 287 0.6× 276 0.6× 398 1.4× 253 1.0× 463 2.0× 93 1.5k
Lothar Hambach Germany 17 397 0.9× 284 0.6× 74 0.3× 208 0.8× 212 0.9× 35 974

Countries citing papers authored by Sawa Ito

Since Specialization
Citations

This map shows the geographic impact of Sawa Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sawa Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sawa Ito more than expected).

Fields of papers citing papers by Sawa Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sawa Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sawa Ito. The network helps show where Sawa Ito may publish in the future.

Co-authorship network of co-authors of Sawa Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Sawa Ito. A scholar is included among the top collaborators of Sawa Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sawa Ito. Sawa Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Sawa, Erik W. Martin, Constantinos G. Panousis, et al.. (2025). High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens. Blood Advances. 10(4). 1114–1125.
2.
Ahmed, Gulrayz, Anikó Szabó, Mazyar Shadman, et al.. (2024). CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience. Blood Advances. 8(13). 3528–3531. 2 indexed citations
3.
Hou, Jing‐Zhou, et al.. (2024). Maintenance strategies for relapse prevention and treatment. Hematology. 2024(1). 635–643.
4.
Neupane, Biswas, et al.. (2023). A Necroptosis Inhibitor Functions As a Ferroptosis Inducer in Drug-Resistant Myeloid Malignancies. Blood. 142(Supplement 1). 413–413. 1 indexed citations
6.
Moore, Erika, Elizabeth F. Krakow, Geoffrey R. Hill, et al.. (2023). Pilot Trial of Interferon-γ and Donor Lymphocyte Infusion to Treat Relapsed Myeloblastic Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(2). S45–S46. 3 indexed citations
7.
Chen, Marcus Y., Sujata M. Shanbhag, Xin Tian, et al.. (2020). Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors. SHILAP Revista de lepidopterología. 2(3). 109–109. 4 indexed citations
9.
Ito, Sawa, Jeffrey R. Strich, Maura Manion, et al.. (2017). Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection. Leukemia Research Reports. 8. 4–6. 7 indexed citations
10.
Merideth, Melissa A., Priyanka A. Pophali, Sawa Ito, et al.. (2017). Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study. Bone Marrow Transplantation. 53(1). 78–83. 17 indexed citations
11.
Tian, Xin, Neil Dunavin, Nancy F. Hensel, et al.. (2016). Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system. Bone Marrow Transplantation. 51(12). 1615–1616.
12.
Dumitriu, Bogdan, Sawa Ito, Xingmin Feng, et al.. (2015). Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. The Lancet Haematology. 3(1). e22–e29. 39 indexed citations
13.
Dunavin, Neil, Christopher S. Hourigan, Robert Q. Le, et al.. (2015). CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation. Supportive Care in Cancer. 24(2). 815–822. 5 indexed citations
14.
Kennedy‐Nasser, Alana A., Stephanie Ku, Yasmin Hazrat, et al.. (2014). Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity. Clinical Cancer Research. 20(8). 2215–2225. 145 indexed citations
15.
Ito, Sawa, Pawel Muranski, Christopher S. Hourigan, et al.. (2014). The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches. Cytotherapy. 16(7). 927–933. 54 indexed citations
16.
Chinnasamy, Dhanalakshmi, Pawel Muranski, Sawa Ito, et al.. (2013). Generation Of Anti-Tumor CD4+ T Helper Cells Using Genetically-Engineered Dendritic Cells Expressing Leukemia-Associated Antigens. Blood. 122(21). 2027–2027.
17.
Ito, Sawa, Priyanka A. Pophali, Gary A. Fahle, et al.. (2013). CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplantation. 48(10). 1313–1316. 79 indexed citations
18.
Battiwalla, Minoo, David F. Stroncek, Deborah E. Citrin, et al.. (2012). Outcomes After CD34+ Selection With or Without the Addition of Photo-Allodepleted T Lymphocytes in Myeloablative HLA-Matched Sibling Transplantation. Biology of Blood and Marrow Transplantation. 18(2). S260–S260. 1 indexed citations
19.
Melenhorst, J. Joseph, Colin O. Wu, Sawa Ito, et al.. (2012). Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant. Haematologica. 98(3). 346–352. 18 indexed citations
20.
Yang, Qian, Sawa Ito, & Frank J. Gonzalez. (2007). Hepatocyte-restricted constitutive activation of PPAR  induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis. 28(6). 1171–1177. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026